Search clinical trials for: MiniMed 780G

Total 88 results

Medtronic Diabetes

Completed

Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes (SMILE)

Type 1 Diabetes

Netherlands, France, Italy, United Kingdom
Bruce A. Buckingham

Completed

Medtronic Minimed Overnight Closed-Loop System

Type 1 Diabetes Mellitus | Autoimmune Diabetes | Juvenile-Onset Diabetes | Diabetes, Mellitus, Type 1

United States
Aristotle University Of Thessaloniki

Unknown

Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

Type 1 Diabetes

Greece
Medtronic Corporate Technologies and New Ventures

Completed

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C (COPE-HCV)

Hepatitis C

United States
Sidra Medical and Research Center

Completed

Evaluation of Minimed 670G in T1D Patients on Multiple Daily Injection

Diabetes Mellitus, Type 1

Qatar
Medtronic Diabetes

Completed

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Diabetes

United States
Medtronic Diabetes

Completed

Obtain a Good Blood Glucose Control With the Paradigm Real Time System (RTD)

Type 1 Diabetes

France
University of North Carolina, Chapel Hill
AstraZeneca; Medtronic

Completed

Intravenous Exenatide in Patients With Acute Brain Injury

Brain Injuries

United States
Jessa Hospital

Completed

Comparison Between Enlite and Flash Glucose Monitoring

Type1 Diabetes Mellitus

Belgium
Stanford University
Medtronic

Completed

Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy (STAR3)

Type 1 Diabetes

United States, Canada
Medtronic Diabetes

Completed

OpT2mise Glucose Control in Type 2 Diabetes Mellitus (DM) With Insulin Pump Therapy (OpT2mise)

Diabetes Mellitus, Type 2

United States, France, Germany, Austria, Canada, Hungary, Israel, Italy, Macedonia, The Former Yugoslav Republic of, Netherlands, Serbia, South Africa, Spain
Kinderkrankenhaus auf der Bult

Completed

Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D) (DREAM5)

Type 1 Diabetes

Germany
Sanofi

Completed

Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes

Diabetes Mellitus, Type 1

Belgium, France, Netherlands, Sweden
Institut de Recherches Cliniques de Montreal
Juvenile Diabetes Research Foundation

Withdrawn

Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
University Hospital, Grenoble

Completed

Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia (ALPPHY)

Diabetes, Type 1

France
Medtronic Diabetes

Completed

In Clinic Evaluation of the PLGM Feature (PLGM)

Type 1 Diabetes

United States
Becton, Dickinson and Company

Withdrawn

The PSIQS Study - User Experience With Pro-Set

Diabetes Mellitus, Type 1
Johns Hopkins University
National Institutes of Health (NIH); Medtronic

Completed

Medtronic MiniMed Implantable Insulin Pump

Type 1 Diabetes

United States
Amsterdam UMC, location VUmc
Eli Lilly and Company

Completed

The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA (INCONTROL)

Type 1 Diabetes Mellitus | Hypoglycemia Unawareness

Netherlands
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 640G Insulin Pump

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Australia
Medtronic Diabetes

Completed

Assess the Efficacy of the Low Glucose Suspend (LGS) Feature in the MiniMed Paradigm® X54 System

Type 1 Diabetes Mellitus

United States
Becton, Dickinson and Company

Completed

A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces

Diabetes

United States
Medtronic Diabetes

Completed

User Evaluation of the MiniMed 620G and 640G Insulin Pumps

Type 1 Diabetes | Type 2 Diabetes

United Kingdom, Denmark, Australia, Spain
Kinderkrankenhaus auf der Bult
Medtronic International Trading Sarl

Completed

"MiniMed 640G System" User Evaluation With the Question of Reducing the Rate of Hypoglycemia

Type 1 Diabetes

Germany
University of Ljubljana, Faculty of Medicine

Completed

Prevention of Hypoglycaemia With Predictive Insulin Suspend Using Sensor Augmented Insulin Pump in Children (SportGuard)

Type 1 Diabetes Mellitus

Slovenia, Israel
Steen Andersen
Medtronic

Completed

Effect of CSII and CGM on Progression of Late Diabetic Complications

Type 1 Diabetes Mellitus

Denmark
Insuline Medical Ltd.

Completed

Evaluation of the Effect of the InsuPatch Device on Insulin Pharmacokinetics in Clamp Studies

Diabetes Mellitus, Insulin-Dependent

Israel, United States
Insuline Medical Ltd.

Completed

Evaluation of the Safety Use of the InsuPatch Device in Daily Life Conditions (Daily Life)

Diabetes Mellitus, Type 1

Israel, United States
Yale University
Medtronic

Withdrawn

Continuous Glucose Monitoring Technology in the Perioperative Period During Cardiac Surgery

Cardiac Surgery
Medtronic Diabetes

Completed

An Inpatient Evaluation of Six-Day Subcutaneous Glucose Sensor Performance (6-DayFU)

Diabetes

United States
Institut de Recherches Cliniques de Montreal
McGill University; Montreal Children's Hospital of the MUHC; Diabetes Québec; Medtronic...

Completed

Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 Diabetes (CLASS-01)

Type 1 Diabetes

Canada
Children's Mercy Hospital Kansas City
Leadiant Biosciences, Inc.; Minimed Pharmaceuticals; Pharmacia/Upjohn Career...

Completed

Carnitine Levels and Carnitine Supplementation in Type I Diabetes

Hypoglycemia | Diabetes Mellitus, Type I

United States
Medtronic Diabetes

Completed

Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration (MIP310)

Type 1 Diabetes

United States
Seattle Children's Hospital
Medtronic; The Gerber Foundation

Unknown

The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children (Gerber RTSA)

Diabetes Mellitus, Type I

United States
Medtronic Diabetes

Completed

Feasibility Study for Training Pump Naïve Subjects To Use The Paradigm® System And Evaluate Effectiveness (STAR2)

Type 1 Diabetes

United States
University of Oklahoma
Oklahoma Center for the Advancement of Science and Technology

Terminated

Glucose Control In Hematopoetic Stem Cell Transplant

Hyperglycemia | Hematopoietic Stem Cell Transplantation

United States
Stanford University
Medtronic

Completed

Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit

Hyperglycemia

United States

Search clinical trials for: MiniMed 780G

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations